METROWEST MEDICAL CENTER — History
CCN 220175 | 3-year financial timeline | COVID resilience: 34/100
🛡️ Public data only — no PHI permitted on this instance.
$208M
Latest Revenue (FY2022)
-1.0%
Revenue CAGR (3yr)
-11.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $213M | $229M | $208M | -8.9% | -1.0% |
| Operating Expenses | $239M | $237M | $232M | -2.3% | -1.5% |
| Operating Margin | -12.5% | -3.7% | -11.3% | -205.0% | +0.0% |
| Net Income | $-27M | $-8M | $-24M | -177.8% | +0.0% |
| Licensed Beds | 210 | 144 | 143 | -0.7% | -17.5% |
| Total Patient Days | 35,360 | 33,563 | 30,938 | -7.8% | -6.5% |
| Medicare Day % | 35% | 33% | 34% | +2.1% | -1.4% |
| Medicaid Day % | 14% | 17% | 16% | -4.8% | +8.6% |
COVID Impact & Recovery
Resilience Score: 34/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -2.0% ($213M → $208M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-1.0%
This Hospital
+7.6%
State Avg
Latest Margin
-11.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $206M | -10.7% |
| FY2024 (proj) | $204M | -10.1% |
| FY2025 (proj) | $202M | -9.5% |